ELDN icon

Eledon Pharmaceuticals
ELDN

Overview Fund Activity

49 hedge funds and large institutions have $69.4M invested in Eledon Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-1
Holders Change %
-2%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
20
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
1
Sabby Management
Florida
$6.77M
2
Bank of New York Mellon
2
Bank of New York Mellon
New York
$6.68M
3
BIT
3
BlackRock Institutional Trust
California
$1.28M
4
NSEDCP
4
NJ State Employees Deferred Compensation Plan
New Jersey
$362K
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$3.49M

Top Sellers

1
TCP
1
Tourbillon Capital Partners
New York
$0
2
KCM
2
Kingdon Capital Management
New York
$6.81M
3
AllianceBernstein
3
AllianceBernstein
Tennessee
$0
4
Ameriprise
4
Ameriprise
Minnesota
$1.14M
5
DCM
5
Discovery Capital Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TCP
51
Tourbillon Capital Partners
New York
– -$6.88M -3,191 Closed
AllianceBernstein
52
AllianceBernstein
Tennessee
– -$613K -285 Closed
DCM
53
Discovery Capital Management
Connecticut
– -$203K -94 Closed
SO
54
STRS Ohio
Ohio
– -$39K -19 Closed
TRCT
55
Tower Research Capital (TRC)
New York
– -$7K -3 Closed
JG
56
Jefferies Group
New York
– -$5K -2 Closed
Invesco
57
Invesco
Georgia
– -$5K -2 Closed
Barclays
58
Barclays
United Kingdom
– -$2K -1 Closed
1 2
3